Literature DB >> 12134092

Activation of the lipopolysaccharide signaling pathway in hepatic transplantation preservation injury.

George Tsoulfas1, Yoshihito Takahashi, Raymond W Ganster, Gautam Yagnik, Zhong Guo, John J Fung, Noriko Murase, David A Geller.   

Abstract

BACKGROUND: Endotoxin or lipopolysaccharide (LPS) initiates a cascade of complications of septic shock and multiple organ failure seen in Gram-negative bacterial infections. The first step of this pathway, which leads to activated nuclear factor (NF)-kappaB, activating protein (AP)-1, and other transcription factors, is the formation of the LPS receptor complex by LPS, LPS-binding protein (LBP), CD14, and toll-like receptor (TLR) 2 or 4. We examined whether the LPS signaling pathway is activated by hepatic ischemia/reperfusion injury in the transplant setting.
METHODS: Orthotopic syngeneic rat liver transplantation was performed with 0 to 18 hr of cold preservation in University of Wisconsin solution. Animals were killed 1 to 48 hr after reperfusion. Northern blot analysis for CD14, LBP, and TLR2 mRNA, immunohistochemistry for LBP, liver enzyme analysis, and gel shift assay for NF-kappaB and AP-1 were performed.
RESULTS: LPS levels were elevated early after reperfusion. Aspartate aminotransferase and alanine aminotransferase maximally increased 12 hr after transplantation. LBP mRNA and protein and CD14 mRNA were significantly up-regulated peaking at 6 to 12 hr after reperfusion. TLR2 mRNA was also increased. NF-kappaB activity showed a biphasic peak at 1 to 3 hr and 12 hr after reperfusion, whereas AP-1 activity showed a peak at 3 to 6 hr. The induction of CD14 mRNA correlated with the length of cold ischemia time.
CONCLUSIONS: These data indicate that multiple components of the LPS signaling pathway are activated during ischemia/reperfusion injury after liver transplantation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12134092     DOI: 10.1097/00007890-200207150-00003

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  16 in total

1.  Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection.

Authors:  Daniel R Goldstein; Bethany M Tesar; Shizuo Akira; Fadi G Lakkis
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

Review 2.  Antigen-presenting cell function in the tolerogenic liver environment.

Authors:  Angus W Thomson; Percy A Knolle
Journal:  Nat Rev Immunol       Date:  2010-11       Impact factor: 53.106

Review 3.  Post reperfusion syndrome during liver transplantation: From pathophysiology to therapy and preventive strategies.

Authors:  Antonio Siniscalchi; Lorenzo Gamberini; Cristiana Laici; Tommaso Bardi; Giorgio Ercolani; Laura Lorenzini; Stefano Faenza
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

4.  Nuclear factor-kappaB decoy oligodeoxynucleotides attenuates ischemia/reperfusion injury in rat liver graft.

Authors:  Ming-Qing Xu; Xiu-Rong Shuai; Mao-Lin Yan; Ming-Man Zhang; Lu-Nan Yan
Journal:  World J Gastroenterol       Date:  2005-11-28       Impact factor: 5.742

5.  Contribution of Toll-like receptor activation to lung damage after donor brain death.

Authors:  Anthony J Rostron; David M W Cork; Vassilios S Avlonitis; Andrew J Fisher; John H Dark; John A Kirby
Journal:  Transplantation       Date:  2010-10-15       Impact factor: 4.939

Review 6.  Steatosis as a risk factor in liver surgery.

Authors:  Reeta Veteläinen; Arlène van Vliet; Dirk J Gouma; Thomas M van Gulik
Journal:  Ann Surg       Date:  2007-01       Impact factor: 12.969

7.  Upregulation of IL-1β, IL-6, and CCL-2 by a novel mouse model of pancreatic ischemia-reperfusion injury.

Authors:  Keri E Lunsford; Brandon J Baird; Gregory D Sempowski; Diana M Cardona; Zhiguo Li; Kent J Weinhold; Debra L Sudan; Todd V Brennan
Journal:  Transplantation       Date:  2013-04-27       Impact factor: 4.939

8.  Interleukin-13 protects mouse intestine from ischemia and reperfusion injury through regulation of innate and adaptive immunity.

Authors:  Douglas G Farmer; Bibo Ke; Xiu-Da Shen; Fady M Kaldas; Feng Gao; Melissa J Watson; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Transplantation       Date:  2011-04-15       Impact factor: 4.939

Review 9.  Linking oxidative stress to inflammation: Toll-like receptors.

Authors:  Roop Gill; Allan Tsung; Timothy Billiar
Journal:  Free Radic Biol Med       Date:  2010-01-18       Impact factor: 7.376

10.  Toll-like receptors in hepatic ischemia/reperfusion and transplantation.

Authors:  John Evankovich; Timothy Billiar; Allan Tsung
Journal:  Gastroenterol Res Pract       Date:  2010-08-05       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.